尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Mull, Craig. Director active across 1 company, notably Cipher Pharmaceuticals Inc.. In total, 12 disclosures have been recorded. History available since 16 March 2024. The latest transaction was filed on 24 June 2026 (57 - Exercise of rights). Regulator: SEDI. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Craig Mull is a director of Cipher Pharmaceuticals Inc. and a senior officer of the company, as well as a 3 - 10% security holder of the issuer. He has 12 filings in total, and in the recent filings available, the reported exercise-of-rights amounts run from 2019-08-09 to 2026-06-25, with a modal transaction nature of 57 - Exercise of rights.